Other languages ProSomnus, Inc.

Equities

OSAPQ

US50535E1082

Market Closed - OTC Markets Other stock markets 14:30:02 21/06/2024 BST			5-day change	1st Jan Change
0.01 ^USD	-15.97%		0.00%	-98.98%

05-24	Joint Reorganization Plan and Disclosure Statement Filed by ProSomnus, Inc.	CI
05-20	ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20
Prosomnus Contributes Two Scientific Abstracts Accepted for Presentation At the 2024 American Academy of Dental Sleep Medicine Annual Meeting	05-13
Motion for Joint Administration Approved for ProSomnus, Inc.	05-09
Motion for Joint Administration Filed by ProSomnus, Inc.	05-07
ProSomnus, Inc. Filed for Bankruptcy	05-07
ProSomnus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
ProSomnus, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-26
Prosomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea	02-22
ProSomnus, Inc. Severe Indication 510(K) Submission Accepts for Review by the Fda	01-30
Top Midday Gainers	12-19
ProSomnus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Prosomnus, Inc. Announces Updated Clinical Trial Data	23/08/23
ProSomnus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/08/23
ProSomnus, Inc. Announces Cessation of Mark Murphy as Executive Officer	28/07/23
ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
ProSomnus, Inc. Announces the Results of a Retrospective Study Demonstrating the Efficacy of Precision Oral Appliance Therapy Compared to Traditional Oat for the Treatment of OSA	24/04/23
ProSomnus Issued US Patent Covering Technology for Precision Sleep Apnea Devices	05/04/23
ProSomnus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
ProSomnus Names Brian Dow Chief Financial Officer	01/03/23
ProSomnus, Inc. Provides Revenue Guidance for the Year Ended December 31, 2022	01/02/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ProSomnus, Inc.

Equities

OSAPQ

US50535E1082

Other languages

Filters